Concepedia

Lingming Kong

LK

12

Publications

611

Citations

12

H-Index

2017

Active since

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Wenzhou Medical University

LMU Klinikum

Ludwig-Maximilians-Universität München

Lingming Kong is an author at China Medical University specializing in tumor biology, cancer cell biology, and cancer biology.

ORCID

Top concepts

Publications per year

2017–2024

12

Publications

12

Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury

Lingming Kong, Jie Deng, Xiang Zhou et al. · Cell Death and Disease · 2021 · 227 citations · Full text

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients

Baohui Zhang, Bufu Tang, Jianyao Gao et al. · Journal of Translational Medicine · 2020 · 141 citations · Full text

<p>The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways</p>

Lingming Kong, Peng Liu, Mingjun Zheng et al. · OncoTargets and Therapy · 2020 · 46 citations · Full text

A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer

Lingming Kong, Peng Liu, Fei Xiang et al. · Frontiers in Oncology · 2020 · 39 citations · Full text

Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis

Peng Liu, Lingming Kong, Haoyi Jin et al. · Cancer Cell International · 2019 · 31 citations · Full text

Rows per page

1–5 of 12